Directory · BE
Biotechnology Research in Belgium
A register of firms and the professionals working at them in the Biotechnology Research sector based in Belgium. Browse the public index, then filter or export on Kipplo.
Companies
344 on file
Ugentec
UgenTec is a molecular laboratory software provider servicing molecular labs, assay and instrument providers globally across applications in Clinical Molecular Diagnostics, Veterinary health, Crop Science, Breeding and Seed Health. UgenTec is headquartered in Hasselt, Belgium with offices in Boston, MA and its FastFinder platform has a global installed base of over 100 molecular labs and partnerships with leading molecular diagnostics vendors. FastFinder is a modular, clinical grade Software as a Service platform using AI methods allowing labs of all sizes to standardize and automate their molecular workflows. FastFinder’s modules include Analysis, Genotyper and Workflow.
11 to 50 staff
Biosenic S.A
BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of immunity, auto-immune diseases and organ repair.
11 to 50 staff
Eptri
EPTRI is a distributed research infrastructure that offers high-quality services in basic, preclinical, and translational pediatric research. Its mission is based on recognizing the importance of growth and ontogeny characteristics in pediatric drug response and the integration of preclinical and clinical research. Through EPTRI's services and Thematic Research Platforms (TRPs), significant advancements are expected in pediatric medicines and other therapeutic and diagnostic approaches. By addressing the research gaps and providing comprehensive support throughout various research phases, EPTRI aims to enhance the development and availability of safe and effective treatments for the pediatric population.
11 to 50 staff
Heiq Chrisal
Founded in Lommel, Belgium, in 1989, the innovative biotech company Chrisal joined with HeiQ Group in 2021. HeiQ Chrisal is the leader in products based on synbiotic ingredients (patented combination of pro- and prebiotics), with a wide range of beneficial application areas in the cleaning, personal care, animal care, water and air treatment fields. The HeiQ Synbio technology uses 100% natural synbiotic ingredients. Synbiotics are a unique combination of pre- and probiotics, formulated and stabilized by HeiQ Chrisal. We share our patented synbiotic technology HeiQ Synbio with other companies to create innovative and reliable products that enhance the natural balance of spaces, people, and the environment.
11 to 50 staff
Axabio
At axabio, we help nutraceutical & cosmetic brands bring winning products to market with the next generation of natural astaxanthin. Produced in Antwerp, the heart of Europe. For Product Innovators and R&D Teams: we use a unique patented photobioreactor, ensuring consistent quality, reliability, and scalability for your product pipeline. For Marketers and Brand Owners: we go beyond the ingredient by offering formulation expertise, marketing materials, and ready-to-use visuals, so you can accelerate launches and build compelling consumer stories. Our focus is simple: Natural advantage: premium, clean-label natural astaxanthin your customers can trust. Market-leading stability: proven performance in complex formulations. True partnership: we don’t just supply—we co-create, helping you succeed from concept to market. With axabio, you gain more than an ingredient. You gain a partner committed to turning your products into a success story.#Astaxanthin #Biotech #Innovation #Sustainability #Health #Beauty #Antioxidant #Nutraceuticals #Cosmetics #FoodSupplements
11 to 50 staff
Biorigin
Biorigin has been responsible for the production of innovative ingredients for human foods and animal nutrition for more than 20 years. Biorigin is always looking into the future, constantly searching for innovative solutions derived from yeast and bacterial fermentation to provide health and the well-being of society.
201 to 500 staff
Deuteroncology Nv
DeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2.
1 to 10 staff
Neurotech Leuven
Neurotechnology is a field that requires the collaboration of students and experts from an incredible diversity of disciplines to function and advance. To facilitate its local advancement, NTL wants to bring talented, like-minded students and experts from the KU Leuven together in a fun, interactive and organized environment. Through NeuroTechX, NTL would be part of a world-wide, non-profit community that supports the communication, education and professional development of its members.
11 to 50 staff
Osivax
Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, “universal” influenza candidate, OVX836, which is currently in Phase 2 clinical trials with over 1200 subjects tested and encouraging efficacy proof of concept data. Osivax’ ambition is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of sarbecovirus in one single shot. The company will expand into other infectious disease indications through combinations and collaborations worldwide.
11 to 50 staff
Perseus Biomics
Perseus Biomics enables researchers and clinicians to perform precise, reproducible and resource-efficient microbiome analysis in laboratories and at point-of-need. Our DynaMAP technology empowers microbiome research, therapeutics and personalized medicine with the goal of improving health.
11 to 50 staff
Pledge Therapeutics
Pledge Therapeutics efforts have given rise to a constellation of exciting discoveries, spanning from early drug hits to preclinical candidates. Our success is based on the rapid translation of clinical and disease insights into target identification and development of novel drug molecules. At the core of our effort is the integration of structural and biophysical knowledge of disease targets to accelerate the pace and success of drug development.
11 to 50 staff
Provinciaal Instituut Voor Biotechnisch Onderwijs
Secundaire school/studiegebied land- en tuinbouw: Bio-STEM. Biotechniek, Natuur. Dubbele finaliteit en arbeidsmarkt. Duaal Leren
51 to 200 staff
Sillar Clinical
Sillar Clinical provides solutions ranging from consultancy and the design, over the set-up, to the full management of clinical development projects. Our customers are biotech, medtech, academic institutions and pharmaceutical companies. Great minds think alike. To unlock your innovations in medical science and to address your unmet needs at any time, we stay ahead of new regulations in clinical development. We help you thrive via our agile step by step approach. Smart transition from preclinical to clinical- We simplify the complex of clinical operations for new therapies and technologies- We think with you by putting pragmatism, creativity and tailor-made solutions at the core of what we do- We guide you to bring your new medical advances to patients- We offer a multitalented team to co-create your tasks with the highest level of effectivity and output quality.
11 to 50 staff
Augustine Therapeutics
Augustine Therapeutics is a biotechnology company focused on the treatment of neuromuscular, neurodegenerative and cardio-metabolic diseases through its next-generation approach to selectively inhibit HDAC6. Augustine’s HDAC6 inhibitors have been purposefully designed to selectively inhibit HDAC6 while preserving its beneficial non-catalytic functions. Augustine’s lead program, AGT-100216, is the first selective HDAC6 inhibitor for long-term treatment of Charcot-Marie-Tooth (CMT) disease. With its novel non-hydroxamate, non-hydrazide producing chemotype, Augustine’s HDAC6 approach is selective, avoids the limitations of other chemotypes, and built for chronic diseases. With this novel approach, the Company will also be targeting diseases beyond CMT, including neurodegenerative and cardio-metabolic diseases. Augustine Therapeutics was founded on the ground-breaking research of Prof. Ludo Van Den Bosch from the VIB-KU Leuven in Belgium. — *Disclaimer* — We wish to caution jobseekers that Augustine Therapeutics, only recruits for the positions that are posted on the company’s webpage and via the channels mentioned there. It will also not charge fees of any kind from candidates during the recruitment process. Any person or organization dealing with unauthorized parties is doing so at their own risk.
11 to 50 staff
Belleaqua
BelleAqua biedt mooie oplossingen voor een zuiver waterbeheer. Van analyse en ontwerp, fabricage, plaatsing en onderhoud. Een persoonlijke aanpak van A tot Z, van Analyse tot Zuiver water.
11 to 50 staff
Biobest
Biobest, we invented the buzziness As a pioneer in the production of bumblebees since 1987, Biobest has become one of the world’s leading companies in natural pollination and biological control of pests and diseases. Known since many years for its bumblebees and wide range of beneficial insects, mites and nematodes, the company now offers a complete range of natural solutions including biopesticides, monitoring and scouting tools, pheromones …. With 28 group companies in 6 continents, distributors in more than 65 countries and over employees worldwide, we stand prepared to provide growers with tailor-made advice. We focus on vegetables, ornamentals, soft-fruits and orchards. With the power of our natural solutions, a successful crop goes hand in hand with a healthy product and a clean environment. Your crop deserves the best! info@biobestgroup.com +32 14 257980
1001 to 5000 staff
Empro Europe
Empro Europe – Protein Works Empro is a Belgian biotech company, founded in 2015 and part of the Damaco Group. At our dedicated facility in Dendermonde, we transform poultry feathers into functional protein ingredients using a patented, chemical-free hydrolysation process. This innovative approach yields high-quality protein meals, hydrolysates and concentrates with excellent digestibility, specific functional properties and natural attractant effects. Our work is driven by scientific research and a strong focus on innovation. We develop customised protein solutions tailored to the needs of each application. Our core markets are aquaculture and premium pet food, where our ingredients offer a sustainable and cost-efficient alternative to conventional proteins. We also serve other sectors including agriculture, animal feed, cosmetics and renewable materials such as biopolymers.
11 to 50 staff
Esobiotec
EsoBiotec is a biotechnology company developing innovative therapeutics to fight cancer. Our mission is to empower the human body to tackle cancer by bringing in vivo engineering of cells to patients. We aim to develop cost-effective and off-the-shelf therapeutics and providing state-of-the-art cell therapies to maximise accessibility. Our disruptive approach holds the potential to transform the current standard of cell and gene therapies for cancer treatment.
11 to 50 staff
Wel Research Institute
Inter-university research institute advancing strategic research and its translation into societal and economic impact in health and sustainable transition, funded by the Walloon Region
1 to 10 staff
Asylia Diagnostics Bv
Asylia, a precision medicine platform, leverages generative AI and multi-modal molecular data to revolutionize immunotherapy safety and efficacy. We provide molecular diagnostics for cancer patients and drug developers, optimizing treatment and boosting clinical trial success.
1 to 10 staff
Atbtherapeutics
atbtherapeutics is a pioneering biopharmaceutical company building a new line of attack against cancer. atbtherapeutics has developed the atbody; a game-changer biologic format designed to broaden the therapeutic window of antibody-based therapies. Only our proprietary and versatile plant-based atbiofarm technology enables single-step manufacturing of our novel class of therapeutic atbodies. The resulting therapeutics offer a novel mechanism of action, avoiding major cancer cell resistance, and provide a promising, life-changing therapy for hard-to-treat and refractory cancer.
11 to 50 staff
Biolynx
We focus on research and development of new processes and products from micro-organisms, mainly (micro-) fungi. We dispose over different species and sorts of equipment we can put to use to find the perfect solution or product according to your needs.
1 to 10 staff
H2win Sa
H2WIN is a Belgian Greentech company founded in 2013 with a unique know-how in the development of enzymatic systems from renewable sources using the biomimicry principles dedicated to industrial applications and to the hydrogen economy. H2WIN is recognised in the industry and academia as being the only company in the world working to produce hydrogen from the direct conversion of sunlight and water with (photo)enzymatic catalysts, the H2GREEN system. H2WIN’s main current development includes H2GREEN, a patented solution to produce green hydrogen (H2) based on photosynthetic enzymes.
1 to 10 staff
Viano
VIANO: een merk, een familiebedrijf, een traditie van innoveren In 1948 richtte Mr. Frans Krauch Sr. ‘Finapar NV’ op, dat afgewerkte producten verkocht van dierlijke oorsprong. Dit was meteen ook de start van het meststoffenmerk Viano. In 1985 nam Frans Krauch Jr. de onderneming van zijn vader over en bracht alles onder de nieuwe naam Rendapart NV. Door deze vroege opstart is VIANO het oudste merk van ORGANISCHE meststoffen op de Belgische markt. Meer dan 65 jaar ervaring heeft geleid tot een hoge productiekwaliteit, een reeks belangrijke productinnovaties door de jaren heen en een uitstekende service voor onze klanten. Viano is niet alleen actief op de Belgische markt, maar ook Europees. Onze organische Viano producten kan je terugvinden in 15 Europese landen.
11 to 50 staff
2grow
By discovering how the plant really responds to all influences and following this real-time, opens up great potential for efficiency growth. We know practically everything from the surrounding area around the plant, but we have no idea how the plant really reacts to it. We want to change this with our products. If we can spread these insights across the industry and combine them with artificial intelligence and machine learning, we can have a positive impact on world level, placing 2Grow one step closer to the ultimate goal.
1 to 10 staff
Agrimex
Agrimex is specialized in the development, production and marketing of specialty products for the feed industry. Besides sales and marketing of its own products throughout Europe, Agrimex is the exclusive distributor for a number of reputable manufacturers of high quality feed ingredients and raw materials. As a member of the Kuge Invest Group, a Belgian holding with a strong focus on nutritional products and services, Agrimex benefits from access to a global network of highly skilled academic and industry professionals. This enables us to be at the leading edge of product innovation and development. In combination with our worldwide access to prime quality raw materials and technologies, our strategic R&D investments and constant focus on providing added value have resulted in a number of top notch products and solutions for the feed industry.
11 to 50 staff
Amyl Therapeutics
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating severe peripheral amyloid protein misfolding diseases. By developing novel therapies that recognize and target multiple misfolded proteins, we aim to make a transformative impact on the lives of patients affected by neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, or by systemic amyloidosis. Our approach is shaped by an experienced team with deep drug development experience, and productive collaborations with world-class advisors and partners.
1 to 10 staff
Bionotus
BioNotus is a Belgium-based CRO providing following services- Bioanalysis (small and large molecules)- Pharmaceutical analysis (e.g. Lipid Nano Particles characterisation)- MetID - ADMET - Proteomics, Peptidomics, Metabolomics, Lipidomics - Pharmacometrics: PBPK modeling, popPK, PKPD, all therapeutic modality agnostic
1 to 10 staff
Hologic Diagenode
Hologic Diagenode is your dedicated supplier for epigenomics profiling services and sample preparation products for next generation sequencing, proteomics, and epigenetics research.
1001 to 5000 staff
Ipratech
The strength of a technical knowledge combined with the expertise acquired in the daily management of a cell culture laboratory allows us to understand specific needs and offer custom solution to any control and automation request. For years, Ipratech has acquired expertise in the development of technological products for any specific applications. Ipratech developped and bring to market own products to make the daily work of cell culture biologist more effective and smooth. Flexibility and swiftness to offer you a unique experience. Since years, Ipratech reduce to pratice a range of technologies applied to cell culture market.
1 to 10 staff
Labomics
LabOmics offers a panel of Molecular and Cellular Biology tools for Life Sciences researchers. LabOmics focuses on serving researchers with first-in-class and innovative kits, reagents and solutions in specific areas such as Genome Editing -CRISPRs, TALENS, transcription regulation, epigenetics, microRNA research and gene expression. Our team members are cell and molecular biologists, who have at least 10 years experience in the above mentioned disciplines, working formerly for the most prestigious companies of this industry. Mission statement Our goal is to give our customers easy and fair access to the most advanced research products together with providing best-in-class support. To be posted about our products release, please send us an email at support@labomics.com
1 to 10 staff
Maash
MAASH is a Belgian biotechnology company founded in 2021 and based in Brussels. Our mission is to supply feed and food producers with a cutting-edge fungal protein alternative, reshaping the narrative of conventional meat sourcing. We are developing innovative solutions to meet the growing demand for alternative proteins and offer a sustainable alternative to the meat industry. MAASH also operates its production plant in France, supporting our scale-up and European footprint.
11 to 50 staff
One2treat
One2Treat is a fast-growing tech company incorporating the patient voice in all strategic decisions about treatment assessments in Pharma R&D. One2Treat is dedicated to transforming the way biopharmaceutical companies design and evaluate clinical trials, and how the overall medical value of a treatment may be communicated, by integrating multiple meaningful dimensions in the treatment assessment
11 to 50 staff
Perseus
Our experts support you with biorisk management and compliance by navigating you through the complex biosafety and biotechnology regulations. Biorisk management covers all aspects of biological safety and security such as inventory management, risk assessment, containment and confinement requirements, training, audit, transport, waste handling, and emergency preparedness. Our team integrates technical background with an in-depth knowledge of the European regulatory requirements for biological material, including genetically modified organisms. We provide assistance in complying with complex regulatory requirements on contained use, workers' protection, pathogens, import and export, emergency planning, deliberate releases such as field trials and clinical trials, and commercial applications. We have a track record in advising on design, following up construction and commissioning, and managing biological safety and operations of up to biosafety level 3 facilities ranging from research laboratories, large-scale production plants, clinical, hospital, and gene therapy settings to plant and animal bio-containment facilities. For genetically modified material, we offer extensive expertise in all life cycle phases, including those that extend beyond containment (e.g. field trials, commercial applications, movement of materials, and imports).
11 to 50 staff
Rootsum
Bij Rootsum geloven we dat elke tuin telt. Onze missie is helder: we willen een netwerk van biodiverse tuinen creëren dat natuurgebieden met elkaar verbindt. Of het nu gaat om een kleine stadstuin, een balkon met potplanten, of een grote moestuin, elke bijdrage maakt een verschil. Samen werken we aan een wereld waarin flora en fauna kunnen floreren.
11 to 50 staff
Seqalis
The mission of Seqalis™ is to provide our customers with cutting-edge and high-quality laboratory testing and techniques but also with scientific advisory and research and development services, in Anatomical Pathology, Cytogenomics and Molecular Biology. Seqalis™ collaborates intensively with its mother company, the Institute of Pathology and Genetics (IPG), one of the eight Belgian Genetics Centres, to continuously foster innovation in the medical and diagnostic fields.
1 to 10 staff
Syngulon
Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins. Our team of scientists works in different academic laboratories and our R&D programs involve partners from Belgium, Spain, France, Switzerland, The Netherlands, and the UK. We think of ourselves as a “Startup in the Labs”, meaning that we work directly in the labs of our academic partners. The members of our Scientific Advisory Board are active in Belgium, France and the USA. The mission of Syngulon is to provide genetic technologies that make microbial strains involved in industrial processes safer and more efficient. Syngulon offers a new selection technology focused on the control of microorganismal growth. This technology is based on the use of bacteriocin/immunity in any bacteria, yeast or algae for controlled growth of microorganisms (EP3035802B1, US Patents / 10,188,114 / 11,427,800, CN ZL 201480057387.2 / ZL 201910882176.7, IN38926, BR1120160035330/BR1220210154171 + US Patent 11,932,672). Syngulon has demonstrated its selection technology’s efficacy at lab scale and is working with customers to use this technology for the production of recombinant products (application in sterile condition). For application in open or semi-open fermentor, Syngulon can customize the bacteriocins based on metagenomic analysis of contaminants.
1 to 10 staff
Taag Labs - Usa
TAAG is a multinational biotechnology company that unites molecular biology and artificial intelligence to catalyze a paradigm shift in how biology is applied in the real world. Traditional R&D pipelines are slow and expensive. We believe innovation should not have a price tag, and progress should match the pace of ambition. Our first-in-class platform enables the rapid development of customized solutions for every application, unlocking unprecedented efficiency and throughput. At every link in the global ecosystem, TAAG helps build a healthier, more sustainable tomorrow. We've partnered with the food & beverage industry, beer & wine, agriculture, water, health, and veterinary industries in developing customized molecular tests and digitally mapped AI driven predictive/preventative environmental monitoring programs. Our solutions can be implemented in our A2LA accredited labs, or in internal labs that are updated to "TAAG ready" molecular labs, or modular labs we can develop.
201 to 500 staff
Takeair
The mission of TakeAir is to create a balanced indoor microbial climate. Biospheric Air Treatment by TakeAir is an automated bio-technology that helps commercial real estate to improve the indoor climate consistently. TakeAir is centrally installed as an add-on to existing ventilation systems. With TakeAir, you don't have to go deep into the forest to breathe the healthiest air. Let's take care of your air!
1 to 10 staff
Tavira Therapeutics
Tavira Therapeutics is a spin-off from KU Leuven developing a modular next-generation AAV capsid platform, with the goal of enhancing tissue-specific transgene delivery for gene therapy
1 to 10 staff
Wellbeing.Ai
Wellbeing.ai provides a people-centric solution by combining the latest emotion-detecting technology with robust human sciences, to improve workplace wellbeing. We are the only service that uses real-time emotional data, to predict declining wellbeing in the workplace, prevent and manage burnout and anxiety at the workplace, and optimise wellbeing within a team. Our task-related AI solution not only can provide individual feedback, but also group customised reporting, as well as comparisons between teams, tasks and business units.
11 to 50 staff
Curavac Europe
CuraVac is a clinical-stage biotech developing a new class of Targeted Active Therapies (TAT) for autoimmune diseases. Our first TAT is for myasthenia gravis (MG). Preclinical work is ongoing for other autoimmune diseases including MS and GBS. Future studies will focus on Graves' disease, Hashimoto's disease, Type 1 Diabetes.
1 to 10 staff
Fox Biosystems
FOx Biosystems aims to revolutionize the life sciences industry and research market using its real-time, label-free analysis technology. The FOx technology is based on an innovative fiber-optic-based surface plasmon resonance biosensor technology. This enables the users to generate high quality biomolecular data such as affinity data, kinetic data and concentration measurements. FOx biosensor technology has several benefits compared to existing biomolecular analysis tools, including ease of use, speed, wide applicability and cost-effectiveness. FOx Biosystems sells instruments, reagents and services to improve biomolecular interaction analysis in life science research and industry. FOx Biosystems was founded in 2016 as a spin-off of the KU Leuven and still closely collaborates with the university for further innovations.
11 to 50 staff
Impact
IMPACT is specialised in research communications and stakeholder engagement, patnering up in projects and initiatives that focus on the biobased segments of the circular economy. Operating from Ghent, we are actively involved in several EU-funded research projects, with an elaborated network on EU level while holding strong ties with local partners.
1 to 10 staff
Labconsult
With over 25 years of experience and an extensive market knowledge, we have built up an impressive portfolio of products, services and solutions for highly diverse laboratory and production environments. Our customers range from academic and clinical research labs over industrial R&D, production- or QC labs to diagnostic labs. From Biomedical Research to Horticulture Production and everything in between. Labconsult is your trusted partner! About us - Privately held company, founded in 1998 - Dedicated team of experienced scientific minds and trained application engineers - Headquarters in Brussels, Warehouse and Customer Service in Ghent - Distribution of scientific supplies in BeNeLux region and worldwide - ISO 9001 certification
1 to 10 staff
Orgenesis Belgium
Orgenesis is a vertically integrated global biotech company working to unlock the full potential of cell and gene therapies (CGTs) in an affordable and accessible format. The Orgenesis Point of Care Platform is comprised of three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. Orgenesis identifies promising new therapies and leverages its POCare Platform to provide a rapid, globally harmonized pathway for these therapies to reach and treat large numbers of patients at lowered costs through efficient, scalable, and decentralized production. The Network brings together patients, doctors, industry partners, research institutes and hospitals worldwide to achieve harmonized, regulated clinical development and production of the therapies. Learn more about the work Orgenesis is doing at Orgenesis Belgium is an affiliate company of Orgenesis Inc. This location carries out process development and validation to support the global commercialization of proprietary and licensed advanced therapies using automated, closed-system technologies.
1 to 10 staff
Breezo
Breezo is dedicated to improving indoor environments by rebalancing them using 100% nature-based beneficial bacteria. Our solutions reduce the need for disinfectants while creating healthier spaces for people to live, work, or meet. Breezo's solutions target yeast, pathogens, and allergens, giving users the same level of indoor comfort that they enjoy outside. Our ultrasonic devices distribute our powerful probiotics throughout your spaces, reducing unpleasant odors while promoting overall wellbeing. With Breezo's subscription model, implementing the new era of indoor air care is hassle-free. Reach out today for more info!
1 to 10 staff
Cartagenia
Cartagenia delivers diagnostic knowledge, software and database systems, and related services to enable genetic labs and clinicians to perform clinically relevant genetic analyses quickly and efficiently, and allow them to offer patients and carers high quality genetic interpretation and counseling.
11 to 50 staff
